|
FKBP9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.140800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.069230E-01 |
| Normal-vs-Stage2 |
4.196400E-01 |
| Normal-vs-Stage3 |
2.543600E-01 |
| Normal-vs-Stage4 |
2.606600E-01 |
| Stage1-vs-Stage2 |
1.225650E-02 |
| Stage1-vs-Stage3 |
7.552800E-01 |
| Stage1-vs-Stage4 |
8.244200E-01 |
| Stage2-vs-Stage3 |
6.215500E-02 |
| Stage2-vs-Stage4 |
7.977900E-02 |
| Stage3-vs-Stage4 |
9.839400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.629160E-01 |
| Normal-vs-AfricanAmerican |
4.111600E-01 |
| Normal-vs-Asian |
5.794600E-01 |
| Caucasian-vs-AfricanAmerican |
6.381700E-02 |
| Caucasian-vs-Asian |
5.464600E-01 |
| AfricanAmerican-vs-Asian |
2.565400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.356200E-01 |
| Normal-vs-Female |
1.756780E-01 |
| Male-vs-Female |
4.552600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.507360E-01 |
| Normal-vs-Age(41-60Yrs) |
1.519640E-01 |
| Normal-vs-Age(61-80Yrs) |
8.517000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.059400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.859600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.581210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.167200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.538990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.138800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.089000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.448840E-01 |
| Classical-VS-Follicular |
9.429600E-01 |
| Classical-VS-Other |
3.197800E-01 |
| Classical-VS-Normal |
3.650800E-01 |
| Tall-VS-Follicular |
2.190800E-01 |
| Tall-VS-Other |
6.638000E-01 |
| Tall-VS-Normal |
7.516100E-02 |
| Follicular-VS-Other |
3.938600E-01 |
| Follicular-VS-Normal |
5.113600E-01 |
| Other-VS-Normal |
1.731630E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.655600E-01 |
| Normal-vs-N1 |
1.949930E-02 |
| N0-vs-N1 |
4.653700E-02 |
|
|
